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Abstract
Tau is known for its pathological role in neurodegenerative diseases, including Alzheimer’s disease (AD) and other
tauopathies. Tau is found in many subcellular compartments such as the cytosol and the nucleus. Although its normal
role in microtubule binding is well established, its nuclear role is still unclear. Here, we reveal that tau localises to the
nucleolus in undifferentiated and differentiated neuroblastoma cells (SHSY5Y), where it associates with TIP5, a key player
in heterochromatin stability and ribosomal DNA (rDNA) transcriptional repression. Immunogold labelling on
human brain sample confirms the physiological relevance of this finding by showing tau within the nucleolus colocalises
with TIP5. Depletion of tau results in an increase in rDNA transcription with an associated decrease in heterochromatin
and DNA methylation, suggesting that under normal conditions tau is involved in silencing of the rDNA. Cellular stress
induced by glutamate causes nucleolar stress associated with the redistribution of nucleolar non-phosphorylated tau, in a
similar manner to fibrillarin, and nuclear upsurge of phosphorylated tau (Thr231) which doesn’t colocalise with fibrillarin or
nucleolar tau. This suggests that stress may impact on different nuclear tau species. In addition to involvement in rDNA
transcription, nucleolar non-phosphorylated tau also undergoes stress-induced redistribution similar to many nucleolar
proteins.
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Background
The microtubule-associated protein, tau, was first de-
scribed as a protein that promotes and stabilises micro-
tubule assembly [43]. It plays a major role in several
neurodegenerative diseases called tauopathies, the most
common of which is Alzheimer’s disease (AD). Tau is
found in both neuronal and non-neuronal cells, has nu-
merous different isoforms and localises to multiple cellu-
lar compartments, indicating that it may play many
cellular roles [6]. However, for nearly 30 years, the ma-
jority of tau research has focused on its role in micro-
tubule biology (stability/assembly) and the implications
associated with tauopathies. In AD, tau becomes hyper-
phosphorylated and/or truncated and forms paired hel-
ical filaments (PHF) that become deposited in
neurofibrillary tangles (NFTs) in the cell bodies of neu-
rons. These structures, together with amyloid plaques,
constitute the main hallmark of AD. The cellular modifi-
cations that accompany the generation of these insol-
uble, fibrous deposits are believed to play an essential
role in neurodegeneration.
A nuclear form of tau has been characterised in sev-
eral cell lines, primary neurons, mouse brain and human
brain tissues (reviewed in [6]. Nuclear tau species are
often visualised distributed throughout the nucleus, de-
pending on the protocol, antibody used and stage of dif-
ferentiation [10, 23]. In neurons, non-phosphorylated
tau is mostly seen in the nucleus [42], but can localise to
the nucleolus during cellular stress [39]. In neuroblast-
oma cells, non-phosphorylated tau appear in puncta that
localise to the nucleolar organiser region [22]. The nu-
cleolus is the major hub for rRNA gene metabolism. Tau
has been found to localise with key nucleolar proteins
like nucleolin and upstream binding transcription factor
(UBF), as well enhance interactions of RNA-binding pro-
teins like T cell intracellular antigen 1 (TIA1) with ribo-
nucleoproteins, suggesting a role for it in rRNA gene
metabolism [4, 37, 41]. Tau has been found to
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co-localise with the pericentromeric heterochromatin
[37], to play a role in its stability [26], and regulate tran-
scription [14]. Tau mutations appear to alter chromo-
some stability [35], while tau pathology induces
chromatin relaxation [11, 14].
Non-phosphorylated tau has been found to translo-
cate to the nucleus playing a role in DNA protection
during heat stress [39]. Other reports demonstrate
that stress induced by formaldehyde or Aβ42 pro-
motes the nuclear influx of phosphorylated species
of tau and this coincides with cellular and DNA
damage [24, 25, 31]. These studies suggest that nu-
clear species of tau may be affected differently de-
pending on the type or severity of the cellular stress.
However, it is not clear whether the nuclear phos-
phorylated tau accumulates in the nucleolus and
whether the species of tau localised to the nucleolus
behaves like nucleolar proteins, such as nucleophos-
min (B3) and fibrillarin (FBL) which become redis-
tributed during nucleolar stress [19]. Nucleolar stress
is thought to be an early event in cellular dysho-
meostasis, preceding apoptosis and occurs in neuro-
degeneration [2, 8, 40, 44].
To understand the role of tau on nucleolar function
and impact of cellular stress on its nucleolar localisation,
here we show that nuclear non-phosphorylated tau lo-
calises within the nucleolus in undifferentiated and dif-
ferentiated human SHSH5Y neuroblastoma cells, where
it associates with TIP5, the major subunit of the Nucle-
olar Remodelling Complex (NoRC) and a key player of
heterochromatin stability at constitutive heterochroma-
tin and rDNA [34]. We reveal that tau knockdown leads
to an increase in rDNA transcription and associated de-
stabilisation of the heterochromatin indicating that it
plays a role in rDNA transcription. Furthermore, glu-
tamate induced stress causes a redistribution of nucle-
olar tau associated with nucleolar stress indicating that
tau behaves like other nucleolar proteins. Immunogold
co-labelling electron microscopy analysis of human brain
tissue sections shows tau localised with TIP5 in the
nucleolus, highlighting the physiological relevance of our
findings.
Methods
Cell culture
Undifferentiated SHSY5Y neuroblastoma cells were
maintained in DMEM/F-12 (Life Technologies, UK),
supplemented with 1% (v/v) L-glutamine 1% (v/v) peni-
cillin/streptomycin and 10% (v/v) Fetal Calf Serum
(FCS). For experiments involving differentiated cells,
SHSY5Y cells were incubated for five days in a medium
containing 1% FCS supplemented with 10 μM
trans-Retinoic acid (Abcam, ab120728), followed by two
days incubation with 2 nM brain-derived neurotrophic
factor (BDNF) in serum-free media (GF029, Merck Milli-
pore). Cells were treated with 2 mM or 20 mM glutamate
(dissolved in DMEM/F-12) or untreated two days
post-BDNF incubation.
siRNA transfection
SHSY5Y cells were maintained for 72 h in Accell
SMARTpool siRNA against Tau (Tau siRNA) or
non-targeting pool (NT siRNA) (Additional file 1:
Table S3) at a concentration of 1.5 μM mixed in
Accell siRNA Delivery Media (B-005000-100,
Dharmacon).
Western blotting
SHSY5Y cells treated or untreated with a test compound
were fractionated using 1X RIPA (Abcam, ab156034),
supplemented with protease (P8340, Sigma) and phos-
phatase (P0044, Sigma). A total of 10 μg of protein from
each sample were loaded to 4-20% Mini-PROTEAN Pro-
tein Gels (4568094, BIO-RAD), for SDS-PAGE at 100 V.
The proteins were transferred to PVDF membrane
(IPVH00010, Merck Millipore) at 100 V, then blocked in
blocking buffer (5% (w/v) milk dissolved in washing buf-
fer (TBS-Tween Tablets solution) (524,753, Merck Milli-
pore), and incubated at 4 °C overnight with the different
primary antibodies (Additional file 1: Table S1) diluted
in the blocking buffer. The membranes were washed in
the wash buffer 5× for 10 min each and probed at RT
on a shaker for 1 h in the corresponding secondary anti-
bodies diluted in blocking buffer. The membranes were
washed 5× for 10 min each and subsequently developed
in the darkroom after incubation in Clarity Western
ECL substrate for 1 min (1,705,060, BIO-RAD). For
loading control antibodies or sequential analyses of other
proteins on the same membrane using other antibodies,
the membranes were stripped using Restore™ PLUS
Western Blot Stripping Buffer (46,428, Thermofisher Sci-
entific), then blocked, and probed as described above.
The blots were scanned at high resolution, and then
bands were quantified using Image J software.
Immunoprecipitation
SHSY5Y cells were fractionated using RIPA supple-
mented with protease and phosphatase inhibitors and
1.25 units of Benzonase Nuclease (E1014, Sigma), and
used at least 2 h afterwards for immunoprecipitation
using Dynabeads protein G according to manufacturers
protocol (10007D, Life technologies). At the final step,
the beads-antibody-antigen complexes were eluted in
30 μL of 50 mM Glycine (pH 2.8) and 15 μL 1×
Laemmli Sample Buffer (1,610,747, BIO-RAD), supple-
mented with 1:10 dilution of 2-Mercaptoethanol (Sigma,
M-6250), and boiled at 80 °C for 10 min. The beads were
separated from the magnet and supernatant (containing
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the eluted protein) and used for SDS-PAGE/Western
blotting.
Immunofluorescence labeling
SHSY5Y cells treated or untreated with a test compound,
were re-suspended in PBS and spun onto a glass slide at
800 RPM for three min using Cytospin Centrifuge (Cell-
Spin I, Tharmac). Cells were fixed with 4% paraformal-
dehyde/PBS for 15 min, PBS-washed, permeabilised
using 0.5% TritonX-100/PBS for 15 min and
PBS-washed. The slides were blocked in blocking buffer
[4% BSA/PBS/Tween-20 (0.02%)] for 45 min, incubated
with primary antibody for 45 min, PBS-washed three
times, incubated in Alexa fluorophore-conjugated corre-
sponding secondary antibody for 45 min. The slides
were PBS-washed three times, incubated in 1/1000
DRAQ5 (ab108410, Abcam) diluted in PBS/Tween-20
(0.02%) for 10 min and mounted with coverslips using
ProLong Gold Antifade mountant (P36930, Life tech-
nologies) or ProLong Gold Antifade mountant with
DAPI (P36935, Life technologies). For the labelling of
5-Methylcytosine /(5-mC), cells on the glass slides were
fixed with 2.5% PFA/PBS for 30 min at RT, PBS-washed,
permeabilised for 1 h at RT with 0.5% Triton X-100/
PBS. The cells were next washed in wash buffer [PBS/
0.1% Triton X-100 (PBST)] and incubated with 2 N HCl
for 30 min at 37 °C to depurinate the DNA, followed by
2 × 5 min wash with 0.1 M borate buffer (pH 8.5). They
were then rinsed twice with PBS-T, blocked in blocking
buffer (1%BSA/PBS-T) for 1 h at RT, incubated with the
primary antibody diluted in the blocking buffer for 2 h
at RT and washed three times in PBS-T. Then they were
incubated with the corresponding secondary antibody
diluted in the blocking buffer for 45 min at RT in the
dark and washed three times in PBS-T, then stained with
DRAQ5 and mounted.
Confocal microscopy imaging and analysis
Images were taken using a 100× oil objective of LSM510
Meta confocal microscope mounted on Axiovert200M
using pinhole size of 1 Airy unit. All images were col-
lected as Z-stacks for all channels using a step size of
1 μm to allow the analysis of the entire signal in the
cells. Subsequently, images were Z-projected to sum all
signals and then analysed using image J. Five randomly
collected images from each experiment and an average
of 150 cells per experiment were subjected to the Image
J analysis. For the quantification of nuclear foci/cluster,
Image J procedure presented by the light microscopy
core facility of Duke University was used [9]. For the
quantification of total nuclear fluorescence intensities,
the nuclei were first segmented by thresholding using
DAPI/DRAQ5 channel, excluding fused nuclei or those
at the edges. Subsequently, the multi-measure option on
the image J ROI manager was used to measure nuclear
fluorescence from all channels in only segmented nuclei.
The total corrected nuclear fluorescence (TCNF) was
then calculated as TCNF = Integrated Density – (Area of
selected cell X Mean fluorescence of background read-
ings [3]. For the quantification of nucleolar nP-Tau and
Fibrillarin redistribution, Z-stack images were
Z-projected to maximum intensity, before cells positive
for the redistribution were counted.
Immunogold labelling transmission Electron microscopy
(TEM)
Brain tissue from the middle frontal gyrus of human
brain (see Additional file 1: Table S2) was analysed
under local ethics approval and provided by London
Neurodegenerative Diseases Brain Bank with informed
consent as previously described [1]. The immunogold la-
belling for these sections and the SHSY5Y cells were
performed by minimal, cold fixation and embedding
protocols, as previously described using an established
method that employs PBS+ buffer for dilution of all
immunoreagents and washes [1, 38]. Thin sections were
collected onto 300-mesh high transmission hexagonal
Nickel grids (Agar Scientific), blocked with normal goat
serum (1:10 dilution) for 30 min at RT, single or doubled
labelled using antibodies for 12 h at 4 °C. The grids were
washed three times with PBS+ for 2 min each, then in-
cubated with appropriate gold particle conjugated sec-
ondary antibodies for 1 h at RT (see antibody section
and results). The grids were next washed three times for
10 min each in PBS+ and four times for 5 min each in
distilled water, dried for 5–10 min and then post-stained
in 0.22 μm-filtered 0.5% (w/v) aqueous uranyl acetate for
1 h in the dark. The grids were finally washed with dis-
tilled water five times at 2 min intervals and left to dry
for at least 12 h before TEM observation.
TEM imaging and analysis
JEOL JEM-1400 Transmission Electron Microscope with
a Gatan OneView® camera was used to image the grids
at 120 V. For colocalisation analysis in the human brain,
four nuclei per grid, of medium to large size (> 50% of
X8000 magnification view), were randomly selected and
imaged at X15000-X20000 magnification. Four grids
were taken from each case, accounting for one repeat
for the two double immunolabelling cases. In all cases,
randomised selection was undertaken by identifying nu-
clei at low magnification (X5000), then imaging at higher
magnification. All images were analysed using Image J.
For colocalization analysis on brain sections, each ob-
served 15 nm gold particle, signifying a Tau 1 antigen,
was checked for colocalisation with 5 nm gold particles,
signifying TIP5 antigens. Our definition of colocalisation
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is; when the number of one antigen (TIP5 particles)
within a 5 0 nm radius of the second antigen (Tau 1) is
greater than zero (n > 0). Gold particles were included in
our analysis if; Tau 1 particles measured between
11≤x≤19 nm and TIP5 particles measured between
1≤x≤9 nm. The method of colocalisation analysis was
roughly based on the cross-K function; we used the
number of gold particles of the first type at distances
shorter than a given distance from a typical particle of
the second type divided by the area of the 50 nm inclu-
sion circle [29].
CellROX green assay
Oxidative stress was measured in treated or untreated
SHSY5Y cells using CellROX Green Reagent (C10444,
Lifetechnologies UK).
Nascent RNA and protein synthesis
Nascent RNA and protein synthesis were visualised re-
spectively using Click-iT RNA Alexa Fluor 488 Imaging
Kit (C10329, Life technologies) and Click-iT HPG Alexa
Fluor 488 Protein Synthesis Assay Kit (C10428, Life
technologies) following the manufacturer’s instructions
and images were taken using a 100× oil objective of
LSM510 Meta confocal microscope mounted on Axio-
vert200M using pinhole size of 1 AU.
RNA Extraction and Complementary DNA (cDNA)
synthesis
RNA was extracted from SHSY5Y cells treated or un-
treated using the protocol supplied by Lifetechnologies
and subsequently used for cDNA synthesis using the
High Capacity cDNA Reverse Transcription Kit
(4,368,814, Life technologies, UK).
Restriction digest for DNA methylation assays
Whole DNA extract from control or Tau knockdown
SHSY5Y cells were digested with 2 U/μL of HpaII
(R6311, Promega) or MspI (R6401, Promega), or they
were mock-digested. T0 region was amplified using
specific primers and samples were run on 10% agarose
gel for quantitative analysis. For further details, see
Additional file 1: Table S4.
Quantitative polymerase chain reaction (qPCR)
Maxima Probe/ROX qPCR Master Mix (2X) (K0232,
Life technologies), 20X TaqMan gene expression assay
(Life technologies UK, Table S4) and Nuclease-free water
were transferred to a white 96-well semi-skirted PCR
plate (I1402–9909-BC, StarLab, UK). A standard curve
was prepared using serial dilution of cDNA and qPCR
was carried out on all samples using Roche LightCycler
480 II (Roche Diagnostics, Basel, Switzerland). See
Additional files for detailed methods.
Statistical analysis
All data were subjected to Kolmogorov-Smirnov (K-S)
normality test and then students t-test using GraphPad
InStat.
Results
Tau localises to the nucleolus in undifferentiated and
differentiated neuroblastoma (SHSY5Y) cells
There is increasing interest in the non-microtubular
roles of the human tau protein. Here we utlised SHSY5Y
neuroblastoma cells to investigate tau’s function in the
nucleus. This human cell line was chosen as a model
system because it expresses human tau at normal levels
without the need for overexpression in transfected or
transgenic primary neurons. Immunogold electron mi-
croscopy using a primary antibody against total tau
(henceforth called T-Tau) confirmed the presence of tau
in the nucleus localised within the nucleolus in the un-
differentiated SHSY5Y cells (Fig. 1a). Nucleolar tau has
been traditionally identified using Tau 1 antibody, which
identifies tau which is non-phosphorylated on serine
195, 198, 199 and 202 [22], henceforth referred to here
as “nP-Tau”. We used an antibody against nP-Tau to in-
vestigate the localisation of nucleolar tau using double
labelling with fibrillarin (FBL) - a nucleolar marker.
Immunofluorescence microscopy showed that nP-Tau
was found mainly in the nucleolus co-localised with FBL
(Fig. 1b). This colocalisation of nP-Tau with FBL was
also confirmed in HeLa cells (Additional file 1: Figure
S1A). To explore this association in more neuron-like,
non-dividing cells, SHSY5Y cells were differentiated
using retinoic acid and brain-derived neurotrophic factor
(BDNF). This generates terminally differentiated cells
that phenotypical and biochemically resemble neurons,
with morphologically distinguishable extended neurites
(Additional file 1: Figure S1B) [18]. Immunofluorescence
confirmed that nP-Tau colocalises with FBL in
differentiated SHSY5Y cells (Fig. 1c).
The localisation of tau to the nucleolus and its role in
pericentromeric heterochromatin stability [26], led us to
investigate whether it associates with Transcription Ter-
mination Factor I-Interacting Protein 5 (TIP5), a protein
that localises to the nucleolar and constitutive hetero-
chromatin and crucial for the stability of these domains
[36]. Immunoprecipitation (IP) revealed that nP-Tau as-
sociates with TIP5 in undifferentiated and differentiated
SHSY5Y cells (Fig. 2ai), suggesting a potential role for
tau in nucleolar heterochromatin processes. Further-
more, double immunogold labelling using primary anti-
bodies against nP-Tau (Tau1) and TIP5, demonstrated
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that tau co-localises with TIP5 in the nucleolus (Fig.
2aii). Together, this revealed that in both undifferenti-
ated and differentiated SHSY5Y cells tau associates with
TIP5. These results show that nucleolar tau retains its
nucleolar localisation and possible function even after
differentiation contrary to previous assumptions that its
role may be not be needed after differentiation [5].
Tau knockdown increases rDNA transcription
Depletion of TIP5 has been previously shown to en-
hance rDNA transcription [34]. To dissect the specific
role of tau in the nucleolus, we investigated whether it
may play a similar or opposing role to TIP5 in the rDNA
transcription regulation. RNA interference using a pool
of non-targetting siRNA as control and a pool targetting
tau were used to transiently deplete tau, then the func-
tional consequence of its down-regulation was investi-
gated. Undifferentiated SHSY5Y cells were incubated for
72 h with 1.5 μM Accell siRNA resulting in a reprodu-
cible and significant loss of tau at both the protein and
mRNA levels (Fig. 2b).
Evidence from tau KO mice showed an enhance-
ment of expression of many genes [32] such as an
increase in pericentromeric heterochromatin tran-
scription [26]. To explore the consequence of tau
Fig. 1 Tau localises to the nucleolus in undifferentiated and differentiated Neuroblastoma (SHSY5Y) cells. a Immunogold labelling of undifferentiated cells
with T-Tau antibody using 10 nm gold particle-conjugated secondary antibody showed tau gold particles within the Nucleolus (1).
Nucleus is highlighted in pink and nucleolus used in second panel is highlighted in blue. The region 1, is identified by a black box.
Representative immunofluorescence fluorescence images showing colabelling for nP-Tau and FBL in undifferentiated (b) and
differentiated (c) cells using Tau 1 antibody shows clear punctate distribution of nP-Tau colocalised with fibrillarin (FBL).
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knockdown on the nucleolus, rDNA transcription
levels were measured. Interestingly, this revealed a
significant increase in 45S-pre-rRNA synthesis and
processing, indicating an increase in rDNA transcrip-
tion (Fig. 2ci). Since nucleolar protein levels are im-
portant for rDNA transcription and/or processing,
the levels of the nucleolar transcription factor,
upstream-binding factor (UBF), and TIP5 were mea-
sured following tau knockdown. There was no differ-
ence between cells treated with tau siRNA and
non-targeting siRNA (Fig. 2cii). Overall, this suggests
that tau could play a role in transcriptional silencing
of the rDNA, similar to TIP5, since its knockdown
allowed an increase in transcription of the rDNA.
Fig. 2 Tau localises with TIP5 and impacts on rDNA transcription and heterochromatin. Immunoprecipitation from whole cell lysates showed that
tau associates with TIP5 in both undifferentiated (U.SHSY5Y) and differentiated cells (D.SHSY5Y) (ai). Double immunogold labelling revealed that
Tau (15 nm) (white arrow) and TIP5 (5 nm) (black arrow) closely associate inside the nucleolus (blue) in SHSY5Y cells (see insert highlighted by
black box) (aii). b Western blotting (i) and qPCR (ii) to confirm siRNA tau knockdown in undifferentiated SHSY5Y cells. ci qPCR on samples from
the knockdown cells showed a significant increase in 45S-pre-rRNA synthesis (rDNA transcription), 18S rRNA and 28S rRNA processing.
[45S pre-rRNA P = 0.017], [18S rRNA P = 0.018]; [28S rRNA P = 0.0038]. (cii) Western blotting shows that proteins levels of TIP5 and UBF are
unchanged in tau knockdown cells. d & e Representative immunofluorescence fluorescence images showing labelling for H3K9me2/
H3K9me3 control and in knockdown cells. Graphs showing quantification from four independent experiments, each with five images and
each containing an average of 30 cells. Quantitative immunofluorescence labelling showed that the tau knockdown resulted in a significant reduction
in the levels of H3K9me2 [P < 0.0001] (D) and number of H3K9me3 foci [P < 0.0001] (e). Labelling for 5-Methylcytosine (5-MC) showed that the tau
knockdown resulted in a significant reduction in the nuclear levels of 5-mC methylation [P < 0.0001] (f). Analysis of HpaII resistance assay showed that
tau knockdown reduces the T0 element methylation (g). *P < 0.05. Experiment Aii = N2. All other experiments N≥ 4
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Tau knockdown impacts on the integrity of the
heterochromatin
Heterochromatin remodelling has been demonstrated
to modulate rDNA transcription [21]. TIP5 has been
shown to be indispensable for heterochromatin for-
mation and rDNA silencing [13, 34]. Given that we
showed an association between tau and TIP5, we
speculated that the increase in rDNA transcription
may result from the influence of tau on heterochro-
matin stability similar to TIP5. H3K9me3 and
H3K9me2 are impermissive epigenetic markers which
are constituents of both nuclear and nucleolar hetero-
chromatin. Depletion of TIP5 has been shown to re-
duce the levels of H3K9me3 [13, 34]. In untreated
SHSY5Y cells, H3K9me2 shows pan-nuclear staining
(Fig. 2d), while the H3K9me3 concentrate in foci that
indicate constitutive heterochromatin (Fig. 2e). To in-
vestigate whether the loss of tau alters the integrity of
the heterochromatin we measured the levels and dis-
tribution of H3K9me3 and H3K9me2 in tau KO cells
and found a decrease in H3K9me3 foci, with an ac-
companying decrease in the total nuclear intensities
of H3K9me2 (Fig. 2d-e), thus showing a loss of het-
erochromatin following the tau knockdown.
Heterochromatin formation is known to be associated
with DNA methylation to provide stability to hetero-
chromatinised genes. To investigate whether tau knock-
down also has consequences on DNA methylation,
nuclear levels of 5-methylcytosine (5-mC) were mea-
sured and found to be significantly reduced following re-
duction of tau (Fig. 2f ). To investigate whether changes
in CpG methylation on rDNA are associated with the
impact of tau knockdown on rDNA transcription, we
measured the level of methylation on the rDNA using
restriction digest. Consistent with finding a reduction in
global DNA methylation (Fig. 2f ), this revealed a signifi-
cant reduction of the CpG methylation of T0 region of
rDNA following the tau knockdown (Fig. 2g). Together,
these findings suggest that the increase in rDNA tran-
scription observed following the tau knockdown likely
resulted from its impact on the heterochromatin, such
that its depletion resulted in heterochromatin loss and
transcription permissive environment leading to in-
creased rDNA transcription.
Nucleolar stress co-occurs with the redistribution of
nucleolar nP-tau
Tau’s localisation and functional role are affected by
cellular stress and during neurodegeneration. To in-
vestigate the impact of cellular stress on nucleolar
tau, differentiated SHSY5Y cells were stressed using
glutamate. Glutamate has been previously shown to
induce toxicity in SHSY5Y cells via a ROS-dependent
mechanism [15], and incubation with up to 80 mM
glutamate was shown to result in
concentration-dependent excitotoxicity at 48 h in both
undifferentiated and differentiated SHSY5Y cells [30].
Differentiated cells incubated with 20 mM glutamate for
2 h resulted in significant oxidative stress, compared to
the untreated control (Fig. 3a).
The nucleolus is susceptible to cellular stress, causing
rapid degradation of nucleolar proteins [7]. To investi-
gate whether the glutamate incubation induces nucleolar
stress, the levels of key nucleolar proteins were exam-
ined. Western blotting for FBL, UBF and TIP5 revealed
a reduction in intensity of the bands for all three pro-
teins and analysis showed a significant decrease in TIP5,
FBL and UBF protein levels in glutamate-treated cells
compared to controls (Fig. 3b). The rapid decrease in
these nucleolar proteins implies that the glutamate treat-
ment directly affects the nucleolus causing its reorgani-
sation. Indeed, different cellular stresses feed into the
nucleolus, leading to the regulation of the energy con-
suming process of ribosome biogenesis through the in-
hibition of rDNA transcription allowing for the
regulation of energy expenditure during stress. To fur-
ther confirm the presence of nucleolar stress, we mea-
sured the levels of 45S pre-rRNA and found that the
glutamate treatment led to a decrease (14%) in 45S
pre-rRNA, indicative of a reduction in rDNA transcrip-
tion (Fig. 3c). These findings revealed that the stress in-
duced by glutamate impacts on the nucleolus, causing
nucleolar stress, which ultimately results in cell death
[40].
Another feature of nucleolar stress is the redistribution
of nucleolar proteins, like FBL [19]. We quantified the
percentage of cells showing FBL redistribution following
the glutamate stress, revealing that 33% of the
glutamate-treated cells showed FBL redistribution to the
nucleoplasm (Fig. 3di and ii). We then investigated
whether nucleolar nP-Tau also undergoes redistribution
due to the glutamate stress. Interestingly, although to a
lesser extent to the FBL redistribution, approximately
14% of the glutamate-treated cells also showed nucleolar
nP-Tau redistribution to the nucleoplasm (Fig. 3di and
iii). All cells that showed nucleolar nP-Tau redistri-
bution also exhibited FBL redistribution, while 19%
of the cells showed only FBL redistribution and
some showed non-punctate, diffuse and decreased
FBL staining, indicating the FBL may have been de-
graded, leaving behind nucleolar nP-Tau (Fig. 3di). A
short incubation of cells with lower concentration of
glutamate (2 mM) also induced FBL redistribution to
a greater extent than nucleolar nP-Tau, but to a
lower extent than changes induced by 20 mM glu-
tamate (Additional file 1: Figure S1C). This suggests
that there is a dose dependent effect of the glutam-
ate stress on nucleolar tau redistribution and also
Maina et al. Acta Neuropathologica Communications  (2018) 6:70 Page 7 of 13
implies that nucleolar nP-Tau is less susceptible to
the stress-induced redistribution/degradation com-
pared to FBL.
Interestingly, while no changes in total levels of tau
were observed, the glutamate incubation results in an in-
crease in cellular levels of nP-Tau by western blotting
(54%) (Fig. 3dv), which could also be observed by
immunofluorescence microscopy (Fig. 3di). This was
in-turn associated with its nuclear accumulation (Fig. 3civ),
similar to previous studies which suggest a role for
this tau species in nuclear protection [39]. Without
impacting on total tau levels, a short incubation with
2 mM glutamate also showed a mild increase in the
levels of nuclear nP-Tau, further highlighting a
concentration-dependent effect (Additional file 1:
Figure S1C, E). Its increase in the nucleus may sug-
gest why nucleolar nP-Tau was less affected by the
glutamate stress compared to FBL.
Fig. 3 Nucleolar stress co-occurs with the redistribution of nucleolar nP-Tau. a Flow cytometry experiments with CellROX Green following 20 mM
Glutamate treatment of differentiated SHSY5Y showed oxidative stress [P= 0.0013]. b Western blotting analysis revealed that the glutamate treatment led
to a significant decrease in TIP5, UBF, and FBL. [TIP5 P < 0.0001]; [UBF P= 0.0004]; [FBL P= 0.0002]. c qPCR analysis of rDNA transcription and processing
showed that the glutamate incubation resulted in a significant decrease in 45S pre-rRNA synthesis [45S pre-rRNA P= 0.008]. d Representative
immunofluorescence fluorescence images showing labelling for nP-Tau and FBL control and following glutamate treatment (Arrows showing regions in
which colocalisation of nP-Tau and FBL is altered by Glutamate treatment). Graphs showing quantification from four independent experiments each with
five images and each containing an average of 35 cells. Glutamate administration resulted in redistribution of nucleolar nP-Tau from FBL (blue arrow), as
well as FBL redistribution from nP-Tau (white arrows) compared to the control. Analysis of immunofluorescence reveals a significant increase in the
number (33%) of cells showing FBL redistribution (dii) [P< 0.02]. Quantification revealed that 14% of Glutamate-treated cells showed nucleolar nP-Tau
redistribution (diii). [P < 0.02]. Total level of nuclear nP-Tau is increased (div) [P< 0.001]. dv Western blotting on whole cell extracts showed a significant
increase in nP-Tau, with no changes in T-Tau levels. nP-Tau [P < 0.0001]; T-Tau: [P= 0.47]. Intensity normalised to β-actin. Images showing nucleolar tau and
FBL in untreated and treated cells were Z-projected for maximum intensity. For all experiments N≥ 4
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Cellular stress induces the accumulation of
phosphorylated tau in the nucleus
Some studies have demonstrated that cellular stress
induces the nuclear influx of phosphorylated species
of tau and this coincides with cellular and DNA
damage [24, 25, 31]. Effects of glutamate stress on
nuclear tau phosphorylation were investigated using
immunofluorescence microscopy employing Z
stacking to enable direct visualisation of the distribu-
tion of nuclear tau with DAPI co-fluorescence to
allow unbiased quantification of the signals through-
out the entire nuclear volume. Interestingly, this re-
vealed that the glutamate administration also led to
an increase in P-Tau (Fig. 4a). Indeed, T-Tau
Fig. 4 Cellular stress induces nuclear accummulation of P-Tau which does not colocalise with nucleolar markers. Representative
immunofluorescence fluorescence images showing labelling for P-Tau and T-Tau control and following glutamate treatment. Graphs show
quantification from four independent experiments, each with five images and each containing an average of 40 cells. Immunofluorescence
microscopy showed a significant increase in nuclear levels of P-Tau (a) and T-Tau (b). T-Tau: [P < 0.0001] and P-Tau: [P < 0.0001]. Double labelling
revealed that the nuclear P-Tau does not colocalise with FBL (c) or nP-Tau (d). N≥ 4
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antibody also showed an increase in nuclear tau sug-
gesting an overall increase in tau species in the nu-
cleus (Fig. 4b). A short incubation of cells with
2 mM glutamate also increased both P-Tau and
T-Tau nuclear levels, although to lesser extent than
with 20 mM glutamate (Additional file 1: Figure S1D).
This shows that the glutamate-induced stress results
in an increase in different tau species in the nucleus
(nP-Tau and P-Tau), which may impact on nuclear
function differently [24, 25, 31, 39]. Importantly, given
that the response observed following both 2 mM and
20 mM Glutamate treatment occured without any
changes in total tau levels (Fig. 3dv and Additional file 1:
Figure S1E), suggesting that the changes in the levels of
nP-Tau and P-Tau observed is not due to an increase in
protein translation.
To investigate whether P-Tau localises to the nucle-
olus, we examined whether P-Tau colocalises with the
nucleolar marker - FBL, or nucleolar nP-Tau. Interest-
ingly, this showed no colocalisation of P-Tau with FBL
or with nP-Tau in control and glutamate-treated cells
(Fig. 4c-d) suggesting that the P-Tau localises in
non-nucleolar nuclear compartment, suggesting distinct
roles for nuclear nP-Tau and P-Tau.
Overall, these results revealed that cellular stress im-
pacts on tau species differently, such that some tau may
become phosphorylated and accumulate in the nucleus
in extra-nucleolar compartments, while nucleolar
nP-Tau becomes redistributed. Collectively, these result
suggest that under normal conditions, tau plays a role in
limiting rDNA transcription, since its depletion leads to
an increase in rDNA transcription similar to TIP5.
Under conditions of nucleolar stress, nucleolar nP-Tau
becomes redistributed similar to other nucleolar proteins
such as FBL, nucleophosmin and TIF-IA [17, 20, 27],
which ultimately results in cell death [40].
Nuclear tau in the human brain
To confirm the presence of nuclear tau in human
tissue, we conducted immunogold electron micros-
copy on middle frontal gyrus tissue sections of hu-
man brain. Although tau in the human brain was
previously visualised in the nucleolus using immuno-
fluorescence microscopy, because the staining was
weak, it was thought that it might not be present in
terminally differentiated cells, such as neurons [5].
Under the transmission electron microscope (TEM),
heterochromatin appears as electron-dense region,
while euchromatin is electron lucent. The nucleolus
often appears as darkly stained, granular spherical
bodies. Immunogold labelling showed that T-Tau lo-
calises in the nucleus, within the nucleolus in the
normal human brain (Fig. 5a). Similarly, and in line
with our findings in SHSY5Y cells, we observed
nP-Tau associates with TIP5 within the nucleolus (Fig. 5b).
Co-localisation analysis of gold particles revealed that
nP-Tau associates with TIP5 as close as 11 nm apart,
and approximately 30% of nuclear nP-Tau is associ-
ated with TIP5 within a 50 nm radius. Overall, these
findings show a relationship between nP-Tau and
TIP5 in both cell models and human brain tissue,
suggesting a functional relevance. These results
demonstrate the presence of nucleolar tau in the hu-
man brain.
Discussion
Here we reveal a close association between tau and TIP5
in the nucleolus in SHSY5Y cells and in human brain tis-
sue. Based on this association and the widely known role
of TIP5 in transcriptional silencing of rDNA, we tested
whether nP-Tau plays a role in rDNA transcription. De-
pletion of tau resulted in increased transcription of
45S-pre-rRNA suggesting a role for nP-Tau in gene si-
lencing and heterochromatin stability. Under conditions
of oxidative stress, nucleolar nP-Tau becomes relocalised
and the levels of nuclear T-Tau and P-Tau (Thr231) in-
crease in a dose dependent manner.
Tau has been shown to localise with acrocentric chro-
mosomes [22] and heterochromatin in human fibro-
blasts, lymphoblasts and HeLa cells [37], suggesting it
may play a role in heterochromatin regulation. A recent
study revealed that tau KO transgenic mice harbour
pericentromeric heterochromatin instability, which can
be rescued by tau overexpression in the nucleus [26].
Here, we reveal that tau localises to the nucleolus in
both SHSY5Y cells and the human brain where it is as-
sociated with TIP5. TIP5 has been shown to interact
with the nucleolar and constitutive heterochromatin
(pericentromeric and telomeric heterochromatin) and
plays a vital role in the establishment of these chromatin
domains [13, 34]. Here we revealed that depletion of tau
led to a reduction in H3K9me3 foci, H3K9me2 nuclear
levels and 5-methylcytosine, indicating heterochromatin
instability. These results suggest that similar to TIP5, tau
may play a role in the heterochromatin complex, such
that its knockdown led to heterochromatin loss, likely
leading to the increase in rDNA transcription. Previ-
ously, tau KO mice also showed that its absence en-
hances the transcription of several genes [32], including
the pericentromeric chromatin [26] and smarce1 gene
[12]. Moreover, tau pathology has been found to induce
chromatin relaxation and enhance the transcription of
many genes suggesting a role for tau in chromatin re-
modelling [11, 14].
How tau is able to affect chromatin conformation re-
mains unclear. However, we found that tau associates
with TIP5 at the perinuclear border, and within the nu-
cleus in the heterochromatin and nucleolus. Such an
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association may suggest that the heterochromatin and
rDNA transcriptional silencing roles of tau may be me-
diated or facilitated by TIP5 or other chromatin remo-
dellers. TIP5, unlike tau, has different domains that
facilitate interaction with chromatin remodellers and the
DNA, such as AT-hooks, a C-terminal PHD and a bro-
modomain [28].
Various cellular stressors are known to induce nucle-
olar stress, a prominent feature of which is the disrup-
tion of the nucleolus and redistribution of nucleolar
proteins such as nucleophosmin and FBL to the nucleo-
plasm or cytoplasm [19, 44]. Redistributed proteins lose
their functional role, resulting to cell death [40]. Here
we showed that glutamate stress induced nucleolar dis-
ruption and redistribution of FBL. However, the striking
result observed here is redistribution of nucleolar
non-phosphorylated tau. Several studies have located tau
in the nucleolus of several cell lines [6, 10], but its dis-
ease involvement or impact of cellular stress on its local-
isation has not been investigated. This study reveals that
nucleolar tau also undergoes stress-induced redistribu-
tion, similar to other nucleolar proteins, demonstrating a
novel involvement of nucleolar tau in nucleolar stress re-
sponse. Interestingly, several regions of the AD brain
have been shown to have a signature of nucleolar stress,
associated with the reduction of several nucleolar pro-
teins and nuclear tau [16]. Given the role of tau in AD
and many tauopathies, future studies will investigate the
changes and contribution of nucleolar tau to the disease
pathology. Interestingly, the nuclear P-Tau (Thr231)
levels increased in response to stress, but did not coloca-
lise with FBL or with nucleolar nP-Tau. P-Tau Ser396/
Ser404 (PHF-1) has been previously shown to localise in
the nucleus but not nucleolus, of a patient with presenile
dementia with motor neuron disease [33]. On the con-
trary, it was recently shown that inhibition of transcrip-
tion with Actinomycin D induces the localisation of
AT-positive tau (Phospho-Tau (Ser202, Thr205) to the
nucleolus in SK-N-BE neuroblastoma cells [10]. This
generally suggest that different nuclear tau species may
Fig. 5 Immunogold electron microscopy to localise tau in the human brain neuronal nucleus. Brain sections labelled with T-Tau (10 nm gold)
showed the presence of tau in the (ai) nucleus and nucleolus (circle in blue) (aii). Double immunogold labelling for Tau 1 (nP-Tau) (15 nm) (white
arrows) and TIP5 (5 nm) (black arrows) showed that they associate in neuronal nucleolus in human brain (bi zoomed in bii, see insert for labelling
in the nucleolus and nucleolar border). Representative images are shown. Single labelling experiments (a) were conducted on sections from two
human cases, while double labelling (b) was conducted on three cases. For both single and double labelling, four grids were taken from each
case, from which four nuclei per grid of medium to large size were randomly selected and imaged
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exist and play different roles in the nucleus during a
stress response.
Conclusions
In this study, we establish the presence of nP-Tau in the
nucleolus in undifferentiated and differentiated SHSY5Y,
HeLa cells and in human brain tissue. We have revealed
a novel association for tau and TIP5 in the heterochro-
matin and nucleolus in SHSY5Y and brain tissue. Al-
though future studies will address the relationship
between Tau and TIP5 in heterochromatin stability and
rDNA transcription, we postulate that the Tau/TIP5
association may function to stabilise the repressive
epigenetic marks on the rDNA and constitutive het-
erochromatin. This work establishes nP-Tau is a bona fide
nucleolar protein which associates with a key member of
the NoRC.
Additional file
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(C) Incubation of cells with 2 mM glutamate led to the redistribution
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Incubation of cells with 2 mM glutamate increased nuclear levels of
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